On July 5, 2025, NewGenIvf Group Ltd.'s Board of Directors approved a reverse stock split, consolidating all issued and unissued shares, including Class A and Class B ordinary shares and preferred shares, at a ratio of one share for every five shares. This move, which does not require shareholder approval, aims to adjust the number of shares without altering their par value. No fractional shares will be issued; instead, shareholders will receive one full share for any fractional entitlements.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewGenIvf Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-061753), on July 07, 2025, and is solely responsible for the information contained therein.